ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,396Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 107

$537K Total Retail Price of All Prescriptions

Rank: 29 out of 107

354 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

11% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 11,772 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 429 429 1 3
METOPROLOL TARTRATE 421 414 2 7
LEVOTHYROXINE SODIUM 393 366 3 1
DONEPEZIL HCL 377 366 4 10
SIMVASTATIN 344 322 5 2
NAMENDA 337 330 6 19
AMLODIPINE BESYLATE 333 306 7 5
LISINOPRIL 302 302 8 4
SERTRALINE HCL 294 293 9 12
OMEPRAZOLE 277 264 10 6
CITALOPRAM HBR 223 223 11 9
ISOSORBIDE MONONITRATE ER 217 217 12 30
WARFARIN SODIUM 208 208 13 8
CLOPIDOGREL 182 174 14 29
CARVEDILOL 182 169 14 25
GABAPENTIN 170 147 16 11
HYDROCODONE-ACETAMINOPHEN 161 160 S3 17 20
TRAZODONE HCL 161 161 17 22
POTASSIUM CHLORIDE 156 156 19 18
EXELON 154 154 20 111
METOPROLOL SUCCINATE 143 143 21 15
METFORMIN HCL 137 137 22 13
RISPERIDONE 131 131 23 26
MIRTAZAPINE 129 121 24 16
LOSARTAN POTASSIUM 124 124 25 36
PLAVIX 122 117 26 43
TAMSULOSIN HCL 109 108 27 27
HYDROCHLOROTHIAZIDE 96 96 28 14
DIOVAN 94 90 29 33
PAROXETINE HCL 93 93 30 80
DIGOXIN 89 89 31 37
ASPIRIN EC 85 85 32 59
QUETIAPINE FUMARATE 84 84 33 31
PREDNISONE 81 81 34 39
VITAMIN D2 80 70 35 238
ESCITALOPRAM OXALATE 78 71 36 40
FLUTICASONE PROPIONATE 75 70 37 54
RAMIPRIL 73 73 38 134
VENLAFAXINE HCL ER 72 32 39 75
ABILIFY 69 53 40 66
ENALAPRIL MALEATE 69 69 40 70
KLOR-CON M20 67 67 42 45
SANTYL 65 65 43 113
HYDRALAZINE HCL 65 55 43 58
RANITIDINE HCL 64 64 45 41
ZOLPIDEM TARTRATE 63 50 46 38
PANTOPRAZOLE SODIUM 62 62 47 28
LEVETIRACETAM 61 57 48 44
TRAMADOL HCL 61 51 48 23
FINASTERIDE 60 59 50 72
CARBIDOPA-LEVODOPA 60 60 50 56
AMIODARONE HCL 59 58 52 93
CYMBALTA 57 57 53 52
NITROGLYCERIN PATCH 56 56 54 222
ALPRAZOLAM 52 52 55 315
ONDANSETRON HCL 51 0 56 174
DILTIAZEM 24HR CD 50 50 57 89
NYSTOP 50 39 57 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.